Search
Solid Tumors Clinical Trials in United Kingdom
A listing of 14 Solid Tumors clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 14
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Solid Tumors
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
There are currently 14 active clinical trials seeking participants for Solid Tumors research studies. The states with the highest number of trials for Solid Tumors participants are .
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Recruiting
TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified combinations in participants with unresectable, locally advanced or metastatic solid tumors determined to harbor specific oncogenic genomic alterations or who are tumor mutational burden (TMB)-high as identified by a validated next-generation sequencing (NGS) assay. Participants with solid tumors... Read More
TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified combinations in participants with unresectable, locally advanced or metastatic solid tumors determined to harbor specific oncogenic genomic alterations or who are tumor mutational burden (TMB)-high as identified by a validated next-generation sequencing (NGS) assay. Participants with solid tumors will be treated with a drug or drug regimen tailored to their NGS assay results at screening. Participants will be assigned to the appropriate cohort based on their genetic alteration(s). Treatment will be assigned on the basis of relevant oncogenotype, will have cohort-specific inclusion/exclusion criteria, and, unless otherwise specified, will continue until disease progression, loss of clinical benefit, unacceptable toxicity, participant or physician decision to discontinue, or death, whichever occurs first. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
08/22/2025
Locations: Southern Cancer Center, Daphne, Alabama +162 locations
Southern Cancer Center, Daphne, Alabama
Western Regional Medical Center at Cancer Treatment Centers of America, Goodyear, Arizona
City of Hope National Medical Center, Duarte, California
Kaiser Permanente Los Angeles, Los Angeles, California
USC Norris Cancer Center, Los Angeles, California
Hoag Memorial Hospital, Newport Beach, California
UC Davis Comprehensive Cancer Center, Sacramento, California
University of California at San Francisco, San Francisco, California
Sarcoma Oncology Center, Santa Monica, California
Children's Hospital Colorado, Aurora, Colorado
Christiana Care Health Srvcs, Newark, Delaware
University of Florida, Gainesville, Florida
Miami Cancer Institute of Baptist Health, Inc., Miami, Florida
Ocala Oncology Center, Ocala, Florida
University Cancer & Blood Center, LLC, Athens, Georgia
St. Alphonsus, Boise, Idaho
Midwestern Regional Med Center, Zion, Illinois
Horizon Oncology Research, Inc., Lafayette, Indiana
New England Cancer Specialists, Scarborough, Maine
Maryland Hematology & Oncology. P.A., Silver Spring, Maryland
St. Joseph Mercy Hospital, Ann Arbor, Michigan
Henry Ford Health System, Detroit, Michigan
University of Minnesota, Minneapolis, Minnesota
Metro-Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota
Washington University, Saint Louis, Missouri
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana, Billings, Montana
Nebraska Methodist Hospital, Omaha, Nebraska
Comprehensive Cancer Centers of Nevada - Eastern Avenue, Las Vegas, Nevada
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
University of New Mexico, Albuquerque, New Mexico
Montefiore Einstein Center for Cancer Care, Bronx, New York
Eastchester Center for Cancer Care, Bronx, New York
National Translational Research Group, New York, New York
Icahn School of Medicine at Mount Sinai, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
New York Cancer and Blood Specialists - Setauket Medical Oncology, Port Jefferson Station, New York
Barrett Cancer Center, Cincinnati, Ohio
Oncology Hematology Care Inc, Cincinnati, Ohio
Providence Portland Medical Center, Portland, Oregon
Consultants in Medical Oncology and Hematology, Broomall, Pennsylvania
Alliance Cancer Specialists, Horsham, Pennsylvania
Virginia Cancer Specialists - Leesburg, Leesburg, Pennsylvania
Cancer Treatment Centers of America, Philadelphia, Pennsylvania
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
PRISMA Health - Greenville, Greenville, South Carolina
The West Clinic, Germantown, Tennessee
St. Jude Children'S Research Hospital, Memphis, Tennessee
Texas Oncology - Central South, Austin, Texas
Mary Crowley Medical Research Center, Dallas, Texas
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas
Cook Childrens Medical Center, Fort Worth, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas
Texas Oncology- Northeast Texas, Tyler, Texas
Northwest Medical Specialties, PLLC, Tacoma, Washington
Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin
Kinghorn Cancer Centre, Darlinghurst, New South Wales
Sydney Children's Hospital, Randwick, New South Wales
Royal Darwin Hospital, Tiwi, Northern Territory
Princess Alexandra Hospital, Woolloongabba, Queensland
Peter MacCallum Cancer Centre, Melbourne, Victoria
Royal Children's Hospital, Parkville, Victoria
Cliniques Universitaires St-Luc, Bruxelles, Not set
GHdC Site Les Viviers, Charleroi, Not set
UZ Antwerpen, Edegem, Not set
UZ Gent, Gent, Not set
UZ Leuven Gasthuisberg, Leuven, Not set
Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul
Hospital Sírio-Libanês, Sao Paulo, São Paulo
Hospital Sírio-Libanês, Sao Paulo, São Paulo
Hospital A. C. Camargo, Sao Paulo, São Paulo
Clínica Onco Star - Rede D'Or, Sao Paulo, São Paulo
BC Cancer ? Vancouver, Vancouver, British Columbia
London Health Sciences Centre · Victoria Hospital, London, Ontario
The Ottawa Hospital - General Campus, Ottawa, Ontario
The Hospital for Sick Children, Toronto, Ontario
Princess Margaret Cancer Center, Toronto, Ontario
McGill University Health Center, Montreal, Quebec
Beijing Cancer Hospital, Beijing, Not set
Beijing Children's Hospital, Capital Medical University, Beijing, Not set
The First Hospital of Jilin University, Changchun City, Not set
Jilin Cancer Hospital, Changchun, Not set
West China Hospital - Sichuan University, Chengdu City, Not set
Shanghai East Hospital, Shanghai City, Not set
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Not set
Zhongshan Hospital Fudan Unvierstiy, Shanghai, Not set
Tianjin Cancer Hospital, Tianjin, Not set
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Not set
Aarhus Universitetshospital, Aarhus N, Not set
Rigshospitalet, København Ø, Not set
Institut Bergonie, Bordeaux, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon, Not set
Hopital de la Timone, Marseille, Not set
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, Not set
Institut de Cancerologie Gustave-Roussy (IGR), Villejuif, Not set
Uniklinik Essen, Essen, Not set
Georg-August-Uniklinik, Göttingen, Not set
Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II, Hamburg, Not set
Medizinische Hochschule Zentrum Innere Medizin Abt.Gastroenterologie, Endokrinologie und Hepatologie, Hannover, Not set
SLK-Kliniken Heilbronn GmbH;Klinik für Innere Medizin III, Heilbronn, Not set
Praxis für Hämatologie, Onkologie und Palliativmedizin, Mönchengladbach, Not set
Klinikum der Universität München, Campus Großhadern, München, Not set
Universtitätsklinikum Ulm, Ulm, Not set
Uniklinikum, Comprehensive Cancer Center Mainfranken, Würzburg, Not set
Hong Kong Children's Hospital, Hong Kong, Not set
Prince of Wales Hospital, Shatin, Not set
Rambam Health Care Campus, Haifa, Not set
Hadassah University Hospital - Ein Kerem, Jerusalem, Not set
Rabin MC, Petach Tikva, Not set
Sheba Medical Center, Ramat Gan, Not set
Sourasky / Ichilov Hospital, Tel Aviv, Not set
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania
Ospedale Pediatrico Bambino Gesù - IRCCS, Roma, Lazio
Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio
Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia
Irccs Istituto Nazionale Dei Tumori (Int), Milano, Lombardia
Istituto Nazionale Tumori di Milano, Milano, Lombardia
Dipartimento di Scienze Pediatriche Adolescenza, Torino, Piemonte
Azienda Ospedaliera Meyer, Firenze, Toscana
Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica, Siena, Toscana
National Cancer Center Hospital East, Chiba, Not set
Kindai University Hospital, Osaka, Not set
National Cancer Center Hospital, Tokyo, Not set
Seoul National University Bundang Hospital, Gyeonggi-do, Not set
Seoul National University Hospital- Adult Site, Seoul, Not set
Seoul National University Hospital- Pediatric Site, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center- Adult Site, Seoul, Not set
Samsung Medical Center- Pediatric Site, Seoul, Not set
Auckland City Hospital, Cancer and Blood Research, Auckland, Not set
Uniwersyteckie Centrum Kliniczne, Klinika Onkologii i Radioterapii, Gda?sk, Not set
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad, Warszawa, Not set
IPO do Porto, Porto, Not set
PanOncology Trials, San Juan, Not set
National University Hospital, Singapore, Not set
National Cancer Centre, Singapore, Not set
Medical Oncology Centre of Rosebank, Johannesburg, Not set
Hospital Sant Joan De Deu, Esplugues De Llobregas, Barcelona
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set
Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set
Hospital Infantil Universitario Nino Jesus, Madrid, Not set
Clinica Universidad de Navarra Madrid, Madrid, Not set
START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
START Madrid. Centro Integral Oncologico Clara Campal, Madrid, Not set
Hospital Universitario la Fe, Valencia, Not set
Universitätsspital Basel (USB), Basel, Not set
Ospedale Regionale di Bellinzona Medizin Onkologie, Bellinzona, Not set
Inselspital, Klinik und Poliklinik für Medizinische Onkologie, Bern, Not set
Unversitätsspital Zürich, Zürich, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Taipei Veterans General Hospital, Taipei City, Not set
Chang Gung Memorial Hospital-Linkou, Taoyuan County, Not set
National Taiwan University Hospital, Zhongzheng Dist., Not set
Beatson West of Scotland Cancer Centre, Glasgow, Not set
University College London Hospital, London, Not set
Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, Not set
Royal Manchester Children?s Hospital, Manchester, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Conditions: Solid Tumors
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Recruiting
The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study.
This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. Each participant will transition to this extension study in one of the following three phases, depending on the study phase they were in at the completion of the par... Read More
The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study.
This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. Each participant will transition to this extension study in one of the following three phases, depending on the study phase they were in at the completion of the parent study. Participants who were in the First Course Phase of study treatment with pembrolizumab or lenvatinib in their parent study will enter the First Course Phase of this study and complete up to 35 doses or more every 3 weeks (Q3W) or 17 doses or more every 6 weeks (Q6W) of study treatment with pembrolizumab or a pembrolizumab-based combination or lenvatinib according to arm assignment. Participants who were in the Follow-up Phase in the parent study (post-treatment or Survival Follow-up Phase) will enter the Survival Follow-up Phase of this study. Participants who were in the Second Course Phase in their parent study will enter Second Course Phase of this study and complete up to 17 doses Q3W or 8 doses Q6W of study treatment with pembrolizumab or a pembrolizumab-based combination according to arm assignment.
Any participant originating from a parent trial where crossover to pembrolizumab was permitted upon disease progression may be eligible for 35 doses as Q3W or 17 doses Q6W of pembrolizumab (approximately 2 years), if they progress while on the control arm and pembrolizumab is approved for the indication in the country where the potential eligible crossover participant is being evaluated. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/19/2025
Locations: Arizona Cancer Center at UMC North ( Site 0018), Tucson, Arizona +666 locations
Arizona Cancer Center at UMC North ( Site 0018), Tucson, Arizona
Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054), Bakersfield, California
California Cancer Associates for Research & Excellence ( Site 0016), Fresno, California
Providence Medical Foundation ( Site 0087), Fullerton, California
The Angeles Clinic and Research Institute ( Site 0005), Los Angeles, California
UCLA Hematology/Oncology - Westwood (Building 100) ( Site 0009), Los Angeles, California
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0076), Orange, California
Stanford Cancer Center ( Site 0086), Palo Alto, California
UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0004), San Francisco, California
Providence Saint John's Health Center ( Site 0059), Santa Monica, California
University of Colorado Cancer Center ( Site 0021), Aurora, Colorado
Yale Cancer Center ( Site 0014), New Haven, Connecticut
Georgetown University Medical Center ( Site 0023), Washington, District of Columbia
Holy Cross Hospital, Michael & Dianne Bienes Comp Cancer Ctr ( Site 0022), Fort Lauderdale, Florida
Baptist MD Anderson Cancer Center ( Site 0083), Jacksonville, Florida
Mount Sinai Medical Center Comprehensive Cancer Center ( Site 0031), Miami Beach, Florida
Moffitt Cancer Center ( Site 0011), Tampa, Florida
Emory School of Medicine ( Site 0013), Atlanta, Georgia
Augusta University ( Site 0077), Augusta, Georgia
Northwest Georgia Oncology Centers PC ( Site 0061), Marietta, Georgia
Kaiser Permanente Moanalua Medical Center ( Site 0063), Honolulu, Hawaii
The University of Chicago ( Site 0020), Chicago, Illinois
University of Iowa Hospital and Clinics ( Site 0026), Iowa City, Iowa
James Graham Brown Cancer Center ( Site 0058), Louisville, Kentucky
Mercy Health-Paducah Cancer Center ( Site 0084), Paducah, Kentucky
Women's Cancer Care ( Site 0088), Covington, Louisiana
MedStar Franklin Square Medical Center ( Site 0046), Baltimore, Maryland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore, Maryland
Maryland Oncology Hematology (MOH) ( Site 8000), Columbia, Maryland
Massachusetts General Hospital ( Site 0041), Boston, Massachusetts
Dana-Farber Cancer Institute ( Site 0006), Boston, Massachusetts
Karmanos Cancer Institute ( Site 0047), Detroit, Michigan
Mayo Clinic in Rochester, Minnesota ( Site 0002), Rochester, Minnesota
Comprehensive Cancer Centers of Nevada ( Site 0043), Las Vegas, Nevada
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0038), Hackensack, New Jersey
Cancer Institute of New Jersey ( Site 0025), New Brunswick, New Jersey
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York, New York
Memorial Sloan Kettering Cancer Center ( Site 0012), New York, New York
White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains, New York
WakeMed Cancer Care - Waverly Hematology & Medical Oncology ( Site 0074), Cary, North Carolina
University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill, North Carolina
Levine Cancer Institute ( Site 0034), Charlotte, North Carolina
Duke Cancer Center ( Site 0028), Durham, North Carolina
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0065), Fargo, North Dakota
University Hospitals ( Site 0044), Cleveland, Ohio
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082), Tulsa, Oklahoma
Providence Portland Medical Center ( Site 0051), Portland, Oregon
St. Luke's University Health Network ( Site 0017), Bethlehem, Pennsylvania
University of Pennsylvania ( Site 0010), Philadelphia, Pennsylvania
Fox Chase Cancer Center ( Site 0042), Philadelphia, Pennsylvania
UPMC Hillman Cancer Center ( Site 0008), Pittsburgh, Pennsylvania
Saint Francis Health System ( Site 0089), Greenville, South Carolina
Sanford Cancer Center ( Site 0066), Sioux Falls, South Dakota
West Cancer Center and Research Institute ( Site 0055), Germantown, Tennessee
Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville, Tennessee
Vanderbilt Ingram Cancer Center ( Site 0015), Nashville, Tennessee
Texas Oncology - Central/South Texas ( Site 8001), Austin, Texas
Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas, Texas
University of Texas MD Anderson Cancer Center ( Site 0007), Houston, Texas
South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001), San Antonio, Texas
University of Virginia Health System ( Site 0035), Charlottesville, Virginia
Bon Secours St. Francis Medical Center-Oncology Research ( Site 0075), Midlothian, Virginia
VCU Health Adult Outpatient Pavillion ( Site 0080), Richmond, Virginia
Blue Ridge Cancer Care ( Site 0067), Roanoke, Virginia
Fred Hutchinson Cancer Center ( Site 0024), Seattle, Washington
Centro de Oncología e Investigación de Buenos Aires ( Site 1357), Berazategui, Buenos Aires
Fundacion Favaloro ( Site 1367), Caba, Buenos Aires
Instituto Alexander Fleming ( Site 1364), Ciudad Autónoma de Buenos Aires, Buenos Aires
IDIM - Instituto de Investigaciones Metabólicas ( Site 1362), Ciudad de Buenos Aires, Buenos Aires
Instituto de Investigaciones Clínicas Mar del Plata ( Site 1363), Mar del Plata, Buenos Aires
Clinica Viedma ( Site 1353), Viedma, Rio Negro
Fundacion Estudios Clinicos ( Site 1369), Rosario, Santa Fe
Sanatorio Parque ( Site 1355), Rosario, Santa Fe
Instituto de Oncologia de Rosario ( Site 1350), Rosario, Santa Fe
Hospital Provincial del Centenario ( Site 1359), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 1351), Buenos Aires, Not set
Hospital Privado Universitario de Córdoba ( Site 1354), Cordoba, Not set
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 1358), La Rioja, Not set
Instituto San Marcos ( Site 1366), San Juan, Not set
Centro Medico San Roque-Oncology ( Site 1352), Tucuman, Not set
Chris OBrien Lifehouse ( Site 3003), Camperdown, New South Wales
Royal Prince Alfred Hospital-A.W. Morrow Gastroenterology and Liver Centre ( Site 3016), Camperdown, New South Wales
Liverpool Hospital-Medical Oncology ( Site 3021), Liverpool, New South Wales
Macquarie University ( Site 3010), Macquarie University, New South Wales
Mater Hospital Sydney ( Site 3007), North Sydney, New South Wales
Orange Hospital-Clinical Trials Unit ( Site 3027), Orange, New South Wales
Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3020), Port Macquarie, New South Wales
Royal North Shore Hospital-Medical Oncology Clinical Trials ( Site 3025), St Leonards, New South Wales
Calvary Mater Newcastle ( Site 3005), Waratah, New South Wales
Westmead Hospital ( Site 3000), Westmead, New South Wales
Melanoma Institute Australia ( Site 3001), Wollstonecraft, New South Wales
Mater Misericordiae Limited-Medical Oncology ( Site 3019), Brisbane, Queensland
Gallipoli Medical Research Ltd ( Site 3011), Brisbane, Queensland
Royal Brisbane and Women's Hospital ( Site 3009), Herston, Queensland
Tasman Oncology Research Pty Ltd ( Site 3012), Southport, Queensland
The Townsville Hospital ( Site 3017), Townsville, Queensland
Princess Alexandra Hospital ( Site 3002), Woolloongabba, Queensland
Royal Adelaide Hospital ( Site 3014), Adelaide, South Australia
The Queen Elizabeth Hospital ( Site 3026), Woodville, South Australia
Monash Health ( Site 3015), Clayton, Victoria
Austin Health-Austin Hospital ( Site 3004), Heidelberg, Victoria
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 3008), Melbourne, Victoria
St Vincent's Hospital-Oncology Clinical Trials ( Site 3018), Melbourne, Victoria
Western Health-Sunshine & Footscray Hospitals ( Site 3023), St Albans, Victoria
Ballarat Oncology & Haematology Services ( Site 3022), Wendouree, Victoria
Sir Charles Gairdner Hospital ( Site 3006), Nedlands, Western Australia
St John of God Subiaco Hospital ( Site 3013), Subiaco, Western Australia
Kepler Universitätsklinikum ( Site 2955), Linz, Oberosterreich
Medical University of Graz ( Site 2952), Graz, Steiermark
Medizinische Universitaet Innsbruck ( Site 2951), Innsbruck, Tirol
Uniklinikum Salzburg ( Site 2956), Salzburg, Not set
Medizinische Universität Wien ( Site 2953), Wien, Not set
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2954), Wien, Not set
AZ Sint-Maarten ( Site 2904), Mechelen, Antwerpen
Institut Jules Bordet ( Site 2903), Anderlecht, Bruxelles-Capitale, Region De
UZ Brussel ( Site 2900), Brussels, Bruxelles-Capitale, Region De
Cliniques universitaires Saint-Luc-Medical Oncology ( Site 2911), Brussels, Bruxelles-Capitale, Region De
Cliniques Universitaires de Bruxelles - CUB - Hopital Erasme ( Site 2905), Bruxelles, Bruxelles-Capitale, Region De
AZ Maria Middelares ( Site 2908), Gent, Oost-Vlaanderen
UZ Leuven ( Site 2901), Leuven, Vlaams-Brabant
UZ Leuven - Campus Gasthuisberg ( Site 2906), Leuven, Vlaams-Brabant
UZ Leuven Gasthuisberg, Gynaecologie-Verloskunde ( Site 2907), Leuven, Vlaams-Brabant
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 2909), Namur, Not set
Hospital São Carlos-Oncocentro Ce ( Site 1029), Fortaleza, Ceara
CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 1024), Fortaleza, Ceara
Centro de Pesquisa Clínica do Instituto do Câncer do Ceará ( Site 1016), Fortaleza, Ceara
ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 1008), Ijui, Rio Grande Do Sul
Hospital de Clínicas de Passo Fundo ( Site 1025), Passo Fundo, Rio Grande Do Sul
Lacks - Oncologia E Hematologia ( Site 1026), Pelotas, Rio Grande Do Sul
Hospital de Clinicas de Porto Alegre ( Site 1000), Porto Alegre, Rio Grande Do Sul
Hospital São Lucas da PUCRS-Centro de Pesquisa em Oncologia ( Site 1006), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição ( Site 1011), Porto Alegre, Rio Grande Do Sul
Clinica Viver ( Site 1021), Santa Maria, Rio Grande Do Sul
CEPON ( Site 1012), Florianópolis, Santa Catarina
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1010), Barretos, Sao Paulo
Hospital Amaral Carvalho ( Site 1023), Jaú, Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site 1003), São José do Rio Preto, Sao Paulo
Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA ( Site 1017), São Paulo, Sao Paulo
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA ( Site 1020), Rio de Janeiro, Not set
Instituto de de Educação, pesquisa e Gestão em Saúde ( Site 1014), Rio de Janeiro, Not set
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 1001), Sao Paulo, Not set
BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 1030), Sao Paulo, Not set
A. C. Camargo Cancer Center ( Site 1002), Sao Paulo, Not set
Arthur J.E. Child Comprehensive Cancer Centre ( Site 2815), Calgary, Alberta
Cross Cancer Institute ( Site 2804), Edmonton, Alberta
CancerCare Manitoba ( Site 2814), Winnipeg, Manitoba
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2801), Hamilton, Ontario
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2808), Kingston, Ontario
London Regional Cancer Program - LHSC ( Site 2806), London, Ontario
The Ottawa Hospital - General Campus ( Site 2813), Ottawa, Ontario
Sunnybrook Research Institute ( Site 2802), Toronto, Ontario
Mount Sinai Hospital ( Site 2811), Toronto, Ontario
Princess Margaret Cancer Centre ( Site 2803), Toronto, Ontario
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre-Oncology ( Site 2809), Greenfield Park, Quebec
Centre Intégré de Santé et de Services Sociaux (CISSS) de La-Centre intégré de cancérologie de Lava ( Site 2810), Laval, Quebec
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 2807), Montreal, Quebec
Jewish General Hospital ( Site 2800), Montreal, Quebec
McGill University Health Centre ( Site 2818), Montreal, Quebec
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 2812), Sherbrooke, Quebec
Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 2816), Trois-Rivières, Quebec
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 2805), Quebec, Not set
James Lind Centro de Investigacion del Cancer ( Site 2757), Temuco, Araucania
Orlandi Oncologia-Oncology ( Site 2752), Santiago, Region M. De Santiago
Fundacion Arturo Lopez Perez FALP ( Site 2750), Santiago, Region M. De Santiago
Oncovida ( Site 2759), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 2751), Santiago, Region M. De Santiago
Instituto Nacional del Cancer-CR Investigación ( Site 2753), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 2756), Santiago, Region M. De Santiago
ONCOCENTRO APYS-ACEREY ( Site 2758), Viña del Mar, Valparaiso
Centro de Investigaciones ( Site 2755), Viña del Mar, Valparaiso
Anhui Provincial Hospital-Cancer Chemotherapy Department ( Site 3480), Hefei, Anhui
Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 3487), Hefei, Anhui
Beijing Cancer Hospital ( Site 3451), Beijing, Beijing
The Fifth Medical Center Of The Chinese PLA General Hospital (South) ( Site 3465), Beijing, Beijing
Beijing Cancer Hospital ( Site 3499), Beijing, Beijing
Beijing Cancer Hospital ( Site 3500), Beijing, Beijing
Beijing Cancer hospital-Thoracic Cancer Department A ( Site 3454), Beijing, Beijing
Chinese Academy of medical science, Peking Union Medical College Hospital(Dongdan) ( Site 3466), Beijing, Beijing
Army Medical Center of People's Liberation Army-Oncology Department ( Site 3477), Chongqing, Chongqing
Fujian Provincial Cancer Hospital ( Site 3461), Fuzhou, Fujian
Southern medical university Nangfang Hospital ( Site 3490), Guanghzou, Guangdong
The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 3491), Guangzhou, Guangdong
SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal Medicine ( Site 3452), Guangzhou, Guangdong
Sun Yat-sen University Cancer Center-melanoma ( Site 3482), Guangzhou, Guangdong
Guangdong Provincial People's Hospital-Cancer Center ( Site 3462), Guangzhou, Guangdong
The First Affiliated Hospital, Sun Yat-sen University-pneumology department ( Site 3459), Guangzhou, Guangdong
The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 3460), Guangzhou, Guangdong
The Affiliated Cancer Hospital of Guizhou Medical University ( Site 3498), Guiyang, Guizhou
Harbin Medical University Cancer Hospital ( Site 3506), Harbin, Heilongjiang
Harbin Medical University Cancer Hospital-Harbin Medical University Cancer Hospital ( Site 3475), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 3488), Zhengzhou, Henan
Tongji Hospital Tongji Medical,Science & Technology-oncology ( Site 3476), Wuhan, Hubei
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3492), Wuhan, Hubei
Xiangya Hospital Central South University-Gynecology ( Site 3497), Changsha, Hunan
Xiangya Hospital Central South University-Respiratory ( Site 3479), Changsha, Hunan
Hunan Cancer Hospital ( Site 3485), Changsha, Hunan
Hunan Cancer Hospital ( Site 3501), Changsha, Hunan
Jiangsu Cancer Hospital-Medical Oncotherapy ( Site 3469), Nanjing, Jiangsu
Yancheng First People s Hospital ( Site 3504), Yancheng, Jiangsu
Northern Jiangsu People's Hospital-General Surgery Department ( Site 3474), Yangzhou, Jiangsu
The First Hospital of Jilin University-Oncology ( Site 3464), Changchun, Jilin
Jilin Province Tumor Hospital ( Site 3484), Changchun, Jilin
Tangdu Hospital of Fourth Military Medical University of Chi-department of radiotherapy ( Site 3455), Xi'an, Shaanxi
Fudan University Shanghai Cancer Center ( Site 3467), Shanghai, Shanghai
Zhongshan Hospital of Fudan University ( Site 3503), Shanghai, Shanghai
Obstetrics & Gynecology Hospital of Fudan University ( Site 3494), Shanghai, Shanghai
Shanghai Pulmonary Hospital ( Site 3470), Shanghai, Shanghai
The First Affiliated Hospital of Xi an Jiaotong University ( Site 3489), XiAn, Shanxi
West China Hospital Sichuan University-respiratory ( Site 3473), Cheng Du, Sichuan
Tianjin Medical University Cancer Institute and Hospital ( Site 3456), Tianjin, Tianjin
Xinjiang Medical University Cancer Hospital - Urumqi-galactophore department ( Site 3486), Urumqi, Xinjiang
The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 3502), Urumqi, Xinjiang
Women s Hospital School of Medicine Zhejiang University ( Site 3493), Hangzhou, Zhejiang
Hangzhou Cancer Hospital-Medical Oncology ( Site 3468), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 3495), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital ( Site 3505), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 3481), Hangzhou, Zhejiang
Instituto de Cancerología-Oncology ( Site 2702), Medellín, Antioquia
Fundacion Colombiana de Cancerología Clinica Vida ( Site 2707), Medellín, Antioquia
Clinica de la Costa S.A.S. ( Site 2705), Barranquilla, Atlantico
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2704), Valledupar, Cesar
IMAT S.A.S ( Site 2703), Montería, Cordoba
Instituto Nacional De Cancerologia-Oncología Clínica ( Site 2706), Bogota, Cundinamarca
Administradora Country S.A. ( Site 2701), Bogota, Distrito Capital De Bogota
Fundación Valle del Lili ( Site 2700), Cali, Valle Del Cauca
Clínica Imbanaco S.A.S ( Site 2708), Cali, Valle Del Cauca
CIMCA ( Site 3900), San Jose, Not set
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0703), Brno, Brno-mesto
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0704), Olomouc, Olomoucky Kraj
Fakultni Thomayerova nemocnice-Onkologicka klinika 1. LF UK ( Site 0702), Prague, Praha 4
Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0705), Praha, Praha 5
Fakultni nemocnice Olomouc ( Site 0701), Olomouc, Not set
Fakultni nemocnice v Motole ( Site 0700), Praha 5, Not set
Odense Universitetshospital ( Site 0650), Odense, Syddanmark
Vejle Sygehus ( Site 0653), Vejle, Syddanmark
Tartu University Hospital-Radiotherapy and oncology ( Site 3800), Tartu, Tartumaa
Tampere University Hospital [Tampere Finland] ( Site 0600), Tampere, Pirkanmaa
Turku University Hospital ( Site 0601), Turku, Varsinais-Suomi
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 2539), Nice, Alpes-Maritimes
Nouvel Hôpital Civil (NHC) ( Site 2529), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque ( Site 2534), Pessac, Aquitaine
Centre Hopitalar Leon-Berard ( Site 2519), Lyon, Auvergne
Hopital Nord ( Site 2516), Marseille, Bouches-du-Rhone
Hôpital Privé Clairval ( Site 2549), Marseille, Bouches-du-Rhone
CHU La Timone ( Site 2508), Marseille, Bouches-du-Rhone
Centre Georges François Leclerc-Centre de recherche clinique ( Site 2536), Dijon, Cote-d Or
CHU Jean Minjoz ( Site 2520), Besancon, Doubs
CHU-Jean Minjoz ( Site 2550), Besançon, Doubs
CHRU Brest - Hopital Cavale Blanche ( Site 2504), Brest, Finistere
Institut Bergonie ( Site 2502), Bordeaux, Gironde
CHU Toulouse - Hopital Rangueil ( Site 2518), Toulouse, Haute-Garonne
CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 2526), Toulouse, Haute-Garonne
Ambroise Pare Hopital ( Site 2503), Boulogne, Hauts-de-Seine
Hôpital Foch ( Site 2543), Suresnes, Hauts-de-Seine
Hôpital Beaujon ( Site 2524), Clichy, Ile-de-France
Groupe hospitalier Paris saint Joseph-Service de Pneumologie-Allergologie -Oncologie Thoracique ( Site 2533), Paris, Ile-de-France
Institut Gustave Roussy ( Site 2513), Villejuif, Ile-de-France
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 2525), Rennes, Ille-et-Vilaine
Hopital Trousseau ( Site 2512), Chambray-les-Tours, Indre-et-Loire
C.H.U. de Tours - Hopital Bretonneau ( Site 2515), Tours, Indre-et-Loire
Institut de Cancérologie de l'Ouest-Oncologie Médicale ( Site 2522), Saint Herblain, Loire-Atlantique
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes-lung oncology ( Site 2546), Saint-Herblain, Loire-Atlantique
Institut de Cancérologie de Lorraine Alexis Vautrin ( Site 2532), Vandoeuvre-lès-Nancy, Lorraine
Centre Oscar Lambret ( Site 2551), Lille, Nord-Pas-de-Calais
CHRU Lille Hospital Claude Huriez ( Site 2506), Lille, Nord
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 2542), Clermont-Ferrand, Puy-de-Dome
CH Lyon Sud Hospices Civils de Lyon ( Site 2521), Pierre Benite, Rhone-Alpes
C.H.U. Pontchaillou ( Site 2511), Pierre Benite, Rhone
Centre Hospitalier du Mans-Pneumologie ( Site 2527), Le Mans, Sarthe
Centre Henri Becquerel ( Site 2547), Rouen, Seine-Maritime
Hôpital Avicenne-Dermatologie ( Site 2538), Bobigny, Seine-Saint-Denis
Clinique de L'Europe ( Site 2548), Amiens, Somme
Centre Hopitalier Intercommunal Creteil ( Site 2514), Creteil, Val-de-Marne
Hôpital Universitaire Paul Brousse ( Site 2541), Villejuif, Val-de-Marne
Centre Hospitalier Universitaire de Poitiers-Dermatologie ( Site 2544), Poitiers, Vienne
Hopital Cochin ( Site 2509), Paris, Not set
Hopital Saint Louis ( Site 2510), Paris, Not set
CHU Hopital Saint Antoine ( Site 2517), Paris, Not set
Groupe Hospitalier Diaconesses Croix Saint Simon ( Site 2545), Paris, Not set
Hôpital Tenon ( Site 2530), Paris, Not set
Universitaetsklinikum Tuebingen ( Site 2405), Tuebingen, Baden-Wurttemberg
Universitätsklinikum Erlangen ( Site 2408), Erlangen, Bayern
Universitaetsklinik Muenchen ( Site 2406), Muenchen, Bayern
Krankenhaus Nordwest ( Site 2409), Frankfurt, Hessen
Elbe Klinikum Buxtehude ( Site 2400), Buxtehude, Niedersachsen
Medizinische Hochschule Hannover ( Site 2402), Hannover, Niedersachsen
Universitaetsklinikum Essen ( Site 2404), Essen, Nordrhein-Westfalen
Universitaetsklinikum des Saarlandes-Klinik für Innere Medizin V-Pneumologie, Allergologie, Beatmun ( Site 2411), Homburg, Saarland
Universitatsklinikum Carl Gustav Carus ( Site 2407), Dresden, Sachsen
LungenClinic Grosshansdorf GmbH ( Site 2412), Grosshansdorf, Schleswig-Holstein
SRH Wald-Klinikum Gera GmbH ( Site 2403), Gera, Thuringen
Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 2418), Berlin, Not set
Facharztzentrum Eppendorf ( Site 2415), Hamburg, Not set
General Hospital of Athens "Laiko"-Hematology Department ( Site 1851), Athens, Attiki
Sotiria Regional Chest Diseases Hospital of Athens ( Site 1850), Athens, Attiki
MEDI-K ( Site 3403), Guatemala, Not set
Oncomedica ( Site 3401), Guatemala, Not set
Grupo Medico Angeles ( Site 3402), Guatemala, Not set
Queen Mary Hospital ( Site 1902), Hksar, Not set
Queen Mary Hospital-Department of Medicine (Respiratory) ( Site 1900), Hksar, Not set
Princess Margaret Hospital ( Site 1903), Hong Kong, Not set
Békés Megyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 1405), Gyula, Bekes
Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház ( Site 1409), Miskolc, Borsod-Abauj-Zemplen
Fejér Megyei Szent György Egyetemi Oktató Kórház-l.Pulmonologia ( Site 1407), Székesfehérvár, Fejer
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 1401), Szolnok, Jasz-Nagykun-Szolnok
Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 1411), Budapest, Pest
Markusovszky Egyetemi Oktatokorhaz-Onkológiai Osztály ( Site 1410), Szombathely, Vas
Farkasgyepui Tudogyogyintezet-Pulmonologia ( Site 1414), Farkasgyepu, Veszprem
Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 1406), Budapest, Not set
Orszagos Koranyi Pulmonologiai Intezet ( Site 1403), Budapest, Not set
Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 1413), Budapest, Not set
Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 1415), Debrecen, Not set
Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 1412), Debrecen, Not set
Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1402), Kaposvar, Not set
Zala Megyei Szent Rafael Korhaz ( Site 1400), Zalaegerszeg, Not set
Mater Misercordiae University Hospital ( Site 1800), Dublin, Leinster
Tallaght University Hospital ( Site 1803), Dublin, Not set
St. James s Hospital ( Site 1801), Dublin, Not set
Rambam Health Care Campus-Oncology Division ( Site 2053), Haifa, Not set
Bnai Zion Medical Center ( Site 2060), Haifa, Not set
Hadassah Ein Kerem Medical Center ( Site 2051), Jerusalem, Not set
Rabin Medical Center ( Site 2059), Petah-Tikva, Not set
Chaim Sheba Medical Center. ( Site 2052), Ramat Gan, Not set
Chaim Sheba Medical Center ( Site 2055), Ramat Gan, Not set
Sheba Medical Center ( Site 2062), Ramat Gan, Not set
Sheba Medical Center ( Site 2065), Ramat Gan, Not set
ZIV Medical Center-Hematology Institute ( Site 2061), Safed, Not set
Sourasky Medical Center ( Site 2054), Tel Aviv, Not set
Shamir Medical Center Assaf Harofeh ( Site 2058), Zerifin, Not set
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1978), Bologna, Emilia-Romagna
Istittuto Nazionale dei Tumori Regina Elena IRCCS - IFO ( Site 1963), Roma, Lazio
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1975), Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1977), Milan, Lombardia
Azienda Ospedaliera San Gerardo ( Site 1980), Monza, Lombardia
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1968), Rozzano, Milano
IRCCS CRO Aviano, Hematology/Oncology ( Site 1957), Aviano, Pordenone
Ospedale Cannizzaro ( Site 1981), Catania, Sicilia
Istituto di Candiolo - IRCCS ( Site 1960), Candiolo, Torino
Ospedale San Luigi Gonzaga ( Site 1956), Orbassano, Torino
AO Santa Maria della Misericordia-Oncology Department ( Site 1971), Perugia, Umbria
Istituto Oncologico Veneto IRCCS ( Site 1976), Padova, Veneto
Humanitas Gavazzeni ( Site 1954), Bergamo, Not set
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII-UOC Oncologia ( Site 1967), Bergamo, Not set
Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 1972), Brescia, Not set
IRCCS A.O.U. San Martino - IST ( Site 1961), Genova, Not set
Ospedale San Raffaele. ( Site 1979), Milano, Not set
Istituto Europeo di Oncologia ( Site 1952), Milano, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1955), Napoli, Not set
Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 1964), Parma, Not set
Fondazione IRCCS Policlinico San Matteo ( Site 1982), Pavia, Not set
Azienda Ospedaliera San Camillo Forlanini ( Site 1958), Roma, Not set
Policlinico Universitario Agostino Gemelli ( Site 1965), Roma, Not set
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 1969), Siena, Not set
Azienda Ospedaliera Santa Maria ( Site 1962), Terni, Not set
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino ( Site 1974), Torino, Not set
Nagoya University Hospital ( Site 3151), Nagoya-Shi, Aichi
National Hospital Organization Nagoya Medical Center ( Site 3109), Nagoya, Aichi
Aichi Cancer Center ( Site 3101), Nagoya, Aichi
National Cancer Center Hospital East ( Site 3121), Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center ( Site 3116), Matsuyama, Ehime
Ehime University Hospital ( Site 3158), Toon,, Ehime
Kurume University Hospital ( Site 3105), Kurume, Fukuoka
National Hospital Organization Hokkaido Cancer Center ( Site 3160), Sapporo, Hokkaido
Sapporo Kosei General Hospital ( Site 3172), Sapporo, Hokkaido
Sapporo Medical University Hospital ( Site 3113), Sapporo, Hokkaido
Hokkaido University Hospital ( Site 3165), Sapporo, Hokkaido
Hyogo Cancer Center ( Site 3131), Akashi, Hyogo
National Hospital Organization Himeji Medical Center ( Site 3111), Himeji, Hyogo
Kobe City Medical Center General Hospital ( Site 3144), Kobe, Hyogo
Hyogo Medical University Hospital ( Site 3100), Nishinomiya, Hyogo
Ibaraki Prefectural Central Hospital ( Site 3180), Kasama, Ibaraki
University of Tsukuba Hospital ( Site 3176), Tsukuba, Ibaraki
Kanazawa University Hospital ( Site 3140), Kanazawa, Ishikawa
Iwate Medical University Hospital ( Site 3157), Shiwa-gun, Iwate
Kagawa University Hospital ( Site 3171), Kita, Kagawa
Nippon Medical School Musashi Kosugi Hospital ( Site 3178), Kawasaki, Kanagawa
St. Marianna University Hospital ( Site 3182), Kawasaki, Kanagawa
Kitasato University Hospital ( Site 3142), Sagamihara, Kanagawa
Yokohama City University Hospital ( Site 3163), Yokohama, Kanagawa
Kanagawa Cancer Center ( Site 3137), Yokohama, Kanagawa
Yokosuka Kyosai Hospital ( Site 3150), Yokosuka, Kanagawa
Miyagi Cancer Center ( Site 3122), Natori, Miyagi
Tohoku University Hospital ( Site 3175), Sendai-shi, Miyagi
Sendai Kousei Hospital ( Site 3115), Sendai, Miyagi
Nara Medical University Hospital ( Site 3110), Kashihara, Nara
Niigata Cancer Center Hospital ( Site 3173), Niigata-shi, Niigata
Kurashiki Central Hospital ( Site 3132), Kurashiki, Okayama
University of the Ryukyus Hospital ( Site 3155), Ginowan, Okinawa
Osaka International Cancer Institute ( Site 3129), Chuo-ku, Osaka
Osaka Habikino Medical Center ( Site 3138), Habikino, Osaka
Kansai Medical University Hospital ( Site 3126), Hirakata, Osaka
Kindai University Hospital ( Site 3102), Osakasayama, Osaka
Kindai University Hospital ( Site 3135), Osakasayama, Osaka
Osaka Rosai Hospital ( Site 3148), Sakai, Osaka
Kindai University Hospital ( Site 3166), Sayama, Osaka
The University of Osaka Hospital ( Site 3168), Suita, Osaka
Osaka Medical and Pharmaceutical University Hospital ( Site 3167), Takatsuki, Osaka
Saitama Medical University International Medical Center ( Site 3118), Hidaka, Saitama
Saitama Prefectural Cancer Center ( Site 3112), Kitaadachi-gun, Saitama
Dokkyo Medical University Saitama Medical Center ( Site 3152), Koshigaya, Saitama
National Defense Medical College Hospital ( Site 3177), Tokorozawa, Saitama
Shizuoka Cancer Center ( Site 3128), Nagaizumi, Shizuoka
Jichi Medical University Hospital ( Site 3141), Shimotsuke, Tochigi
Institute of Science Tokyo Hospital ( Site 3149), Bunkyō, Tokyo
Cancer Institute Hospital of JFCR ( Site 3146), Koto, Tokyo
Cancer Institute Hospital of JFCR ( Site 3164), Koto, Tokyo
Toranomon Hospital ( Site 3134), Minato-ku, Tokyo
Toranomon Hospital ( Site 3153), Minato-ku, Tokyo
Kyorin University Hospital ( Site 3147), Mitaka-shi, Tokyo
Kyorin University Hospital ( Site 3103), Mitaka, Tokyo
Tokyo Medical University Hospital ( Site 3170), Shinjuku-ku, Tokyo
National Hospital Organization Yamaguchi Ube Medical Center ( Site 3123), Ube, Yamaguchi
Yamaguchi University Hospital ( Site 3114), Ube, Yamaguchi
Chiba Cancer Center ( Site 3117), Chiba, Not set
National Hospital Organization Kyushu Medical Center ( Site 3136), Fukuoka, Not set
National Hospital Organization Kyushu Cancer Center ( Site 3169), Fukuoka, Not set
Kyushu University Hospital ( Site 3143), Fukuoka, Not set
Kyushu University Hospital ( Site 3185), Fukuoka, Not set
Gifu University Hospital ( Site 3161), Gifu, Not set
Hiroshima City Hiroshima Citizens Hospital ( Site 3119), Hiroshima, Not set
Hiroshima University Hospital ( Site 3154), Hiroshima, Not set
Kochi Health Sciences Center ( Site 3145), Kochi, Not set
Kumamoto University Hospital ( Site 3179), Kumamoto, Not set
Kyoto University Hospital ( Site 3181), Kyoto, Not set
Niigata University Medical & Dental Hospital ( Site 3174), Niigata, Not set
Okayama University Hospital ( Site 3107), Okayama, Not set
Osaka City General Hospital ( Site 3125), Osaka, Not set
National Hospital Organization Osaka National Hospital ( Site 3162), Osaka, Not set
Osaka General Medical Center ( Site 3184), Osaka, Not set
National Cancer Center Hospital ( Site 3130), Tokyo, Not set
St.Luke's International Hospital ( Site 3120), Tokyo, Not set
The Jikei University Hospital ( Site 3156), Tokyo, Not set
Nippon Medical School Hospital ( Site 3139), Tokyo, Not set
Tokyo Metropolitan Komagome Hospital ( Site 3133), Tokyo, Not set
Cancer Institute Hospital of JFCR ( Site 3108), Tokyo, Not set
Keio University Hospital ( Site 3127), Tokyo, Not set
Teikyo University Hospital ( Site 3104), Tokyo, Not set
Toyama Prefectural Central Hospital ( Site 3183), Toyama, Not set
Wakayama Medical University Hospital ( Site 3124), Wakayama, Not set
Chungbuk National University Hospital ( Site 0961), Cheongju-si, Chungbuk
Gachon University Gil Medical Center ( Site 0967), Inceon, Incheon
Chonnam National University Hwasun Hospital-Hemato-Oncology ( Site 0959), Hwasun, Jeonranamdo
National Cancer Center ( Site 0955), Goyang-si, Kyonggi-do
CHA Bundang Medical Center CHA University ( Site 0957), Seongnam si, Kyonggi-do
Seoul National University Bundang Hospital ( Site 0951), Seongnam-si, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital ( Site 0968), Suwon-si, Kyonggi-do
Gangnam Severance Hospital, Yonsei University Health System ( Site 0966), Gangnam-gu, Seoul
Asan Medical Center ( Site 0952), Songpagu, Seoul
Keimyung University Dongsan Hospital CRC room 1 ( Site 0960), Daegu, Taegu-Kwangyokshi
Kyungpook National University Chilgok Hospital ( Site 0964), Deagu, Taegu-Kwangyokshi
Chungnam national university hospital-Department of Internal Medicine ( Site 0958), Daejeon, Taejon-Kwangyokshi
Korea University Anam Hospital ( Site 0956), Seoul, Not set
Seoul National University Hospital ( Site 0953), Seoul, Not set
Severance Hospital ( Site 0954), Seoul, Not set
Severance Hospital, Yonsei University Health System ( Site 0962), Seoul, Not set
Samsung Medical Center ( Site 0950), Seoul, Not set
Korea University Guro Hospital ( Site 0963), Seoul, Not set
Liepjas reionl slimnca ( Site 3851), Liepaja, Not set
RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia-Out-patient and Day patient facility of Ch ( Site 3850), Riga, Not set
Klaipeda University Hospital-Oncology chemotherapy ( Site 3302), Klaipeda, Klaipedos Miestas
National Cancer Institute-Chemotherapy departament with day care unit ( Site 3301), Vilnius, Vilniaus Miestas
Vilniaus Universiteto Ligonine Santaros Klinikos ( Site 3300), Vilnius, Not set
Hospital Tengku Ampuan Afzan ( Site 0627), Kuantan, Pahang
Gleneagles Penang ( Site 0625), Georgetown, Pulau Pinang
Pantai Hospital Kuala Lumpur ( Site 0628), Kuala Lumpur, Not set
University Malaya Medical Centre ( Site 0626), Kuala Lumpur, Not set
Investigación Oncofarmacéutica-Investigación clínica ( Site 1114), La Paz, Baja California Sur
INSTITUTO NACIONAL DE CANCEROLOGIA ( Site 1102), Ciudad de Mexico, Distrito Federal
Avix Investigación Clinica, S.C.-Oncology ( Site 1104), Monterrey, Nuevo Leon
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 1113), Monterrey, Nuevo Leon
Centro de Urologa Avanzada del Noreste ( Site 1110), San Pedro Garza García, Nuevo Leon
Oaxaca Site Management Organization ( Site 1106), Oaxaca de Juarez, Oaxaca
Medical Care and Research SA de CV ( Site 1103), Merida, Yucatan
Oncare Viaducto Napoles ( Site 1107), Mexico City, Not set
Radboud University Medical Center ( Site 1554), Nijmegen, Gelderland
Antoni van Leeuwenhoek Ziekenhuis ( Site 1551), Amsterdam, Noord-Holland
Amsterdam UMC, locatie VUmc ( Site 1555), Amsterdam, Noord-Holland
Erasmus MC ( Site 1553), Rotterdam, Zuid-Holland
Universitair Medisch Centrum Groningen ( Site 1550), Groningen, Not set
Canterbury Regional Cancer & Blood Service ( Site 1500), Christchurch, Canterbury
Waikato Hospital ( Site 1502), Hamilton, Waikato
Auckland City Hospital ( Site 1503), Auckland, Not set
Capital & Coast District Health Board - Wellington Hospital ( Site 1501), Wellington, Not set
Helse Bergen Haukeland universitetssykehus ( Site 1451), Bergen, Vestfold
Oslo Universitetssykehus Radiumhospitalet ( Site 1450), Oslo, Not set
Oslo universitetssykehus, Radiumhospitalet ( Site 1452), Oslo, Not set
IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0678), Lima, Not set
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0681), Lima, Not set
Hospital Cayetano Heredia-Oncology ( Site 0675), Lima, Not set
Makati Medical Center ( Site 1702), Makati, National Capital Region
Lung Center of the Philippines ( Site 1705), Quezon City, National Capital Region
St. Luke s Medical Center ( Site 1700), Quezon City, National Capital Region
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1612), Bydgoszcz, Kujawsko-pomorskie
Powiatowe Centrum Zdrowia w Brzezinach Sp. z o. o. Oddział Dziennej Chemioterapii ( Site 1611), Brzeziny, Lodzkie
Instytut Centrum Zdrowia Matki Polki-Klinika Onkologii ( Site 1609), Łódź, Lodzkie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 1608), Krakow, Malopolskie
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1618), Kraków, Malopolskie
Luxmed Onkologia sp. z o. o. ( Site 1621), Warszawa, Mazowieckie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 1604), Warszawa, Mazowieckie
Wojskowy Instytut Medyczny-Klinika Onkologii ( Site 1606), Warszawa, Mazowieckie
Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Kosza-Klinika Onkologii z Odcinkiem Dziennym ( Site 1616), Opole, Opolskie
Bialostockie Centrum Onkologii ( Site 1610), Bialystok, Podlaskie
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1620), Gliwice, Slaskie
Przychodnia Lekarska KOMED ( Site 1603), Konin, Wielkopolskie
Med-Polonia Sp. z o. o. ( Site 1605), Poznan, Wielkopolskie
Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna ( Site 1601), Poznan, Wielkopolskie
Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 1619), Poznan, Wielkopolskie
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1614), Koszalin, Zachodniopomorskie
Champalimaud Foundation ( Site 1751), Lisbon, Lisboa
Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 1750), Lisboa, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE-Oncologia Médica ( Site 1753), Porto, Not set
Centro Hospitalar de Sao Joao - Hospital de Sao Joao ( Site 1752), Porto, Not set
Ad-Vance Medical Research-Research ( Site 1151), Ponce, Not set
FDI Clinical Research ( Site 1152), San Juan, Not set
UPR Comprehensive Cancer Center ( Site 1150), San Juan, Not set
Spitalul Județean Sfântul Ioan cel Nou Suceava-Oncology ( Site 3550), Suceava, Not set
Altai Regional Clinical Oncology Center ( Site 1229), Barnaul, Altayskiy Kray
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1204), Ufa, Baskortostan, Respublika
Bashkir State Medical University ( Site 1221), Ufa, Baskortostan, Respublika
Belgorod Oncology Dispensary ( Site 1213), Belgorod, Belgorodskaya Oblast
Regional Budgetary Healthcare Institution 'Ivanovo Regional Oncology Dispensary'-Urology ( Site 1219), Ivanovo, Ivanovskaya Oblast
GBUZ LOKB ( Site 1218), Saint-Petersburg, Leningradskaya Oblast
GBUZ LOKB-Oncology department #1 ( Site 1222), Saint-Petersburg, Leningradskaya Oblast
Ogarev Mordovia State University ( Site 1206), Saransk, Mordoviya, Respublika
The National Medico-Surgical Center N.I. Pirogov ( Site 1225), Moscow, Moskva
N.N. Blokhin NMRCO ( Site 1209), Moscow, Moskva
Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 1201), Moscow, Moskva
FSBI-FRCC of Special Types Med. Care and Technologies FMBA of Russia ( Site 1234), Moscow, Moskva
Russian Scientific Center of Roentgenoradiology ( Site 1215), Moscow, Moskva
P. A. Hertsen Moscow Oncology Research Center ( Site 1214), Moscow, Moskva
FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 1208), Moscow, Moskva
Russian Scientific Research Institute of Hematology and Blood Transfusion-Hematology ( Site 1224), Saint Petersburg, Sankt-Peterburg
First Pavlov State Medical University of Saint Petersburg ( Site 1232), Saint Petersburg, Sankt-Peterburg
Almazov National Medical Research Centre ( Site 1233), Saint Petersburg, Sankt-Peterburg
N.N.Petrov Research Institute of Oncology-Department of Preclinical and Clinical Research ( Site 1211), Saint Petersburg, Sankt-Peterburg
Clinical Research Center of specialized types medical care-Oncology ( Site 1205), Saint-Petersburg, Sankt-Peterburg
EuroCityClinic ( Site 1230), St Petersburg, Sankt-Peterburg
St. Petersburg Clinical Hospital of Russian Academy Of Sciences ( Site 1235), St. Petersburg, Sankt-Peterburg
National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1210), St. Petersburg, Sankt-Peterburg
GBUZ SK Pyatigorsk Interdistrict Oncology dispensary ( Site 1223), Pyatigorsk, Stavropol Skiy Kray
Republican Clinical Oncology Dispensary ( Site 1228), Kazan, Tatarstan, Respublika
Republican Clinical Oncology Dispensary of Tatarstan MoH named after professor M.Z. Sigal ( Site 1203), Kazan, Tatarstan, Respublika
Tomsk Scientific Research Institute of Oncology ( Site 1227), Tomsk, Tomskaya Oblast
SAIH of the Tyumen region, Multidisciplinary Clinical Medical Center "Medical town" ( Site 1220), Tyumen, Tyumenskaya Oblast
Udmurtian Republican Clinical Oncology Center ( Site 1212), Izhevsk, Udmurtskaya Respublika
National Cancer Centre Singapore ( Site 2200), SIngapore, Central Singapore
National University Hospital-Haematology -Oncology Research Group ( Site 2201), Singapore, South West
WCR Office ( Site 2002), Johannesburg, Gauteng
Wilgers Oncology Centre ( Site 2006), Pretoria, Gauteng
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 2005), Pretoria, Gauteng
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 2004), Sandton, Gauteng
The Oncology Centre ( Site 2000), Durban, Kwazulu-Natal
Cape Town Oncology Trials ( Site 2007), Cape Town, Western Cape
GVI Oncology ( Site 2008), George, Western Cape
Hospital Universitario Virgen de la Victoria ( Site 0878), Malaga, Andalucia
Hospital Universitario Central de Asturias-Medical Oncology ( Site 0870), Oviedo, Asturias
Hospital Son Llatzer ( Site 0886), Palma de Mallorca, Baleares
Hospital Universitari Son Espases-Oncologia ( Site 0883), Palma, Baleares
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0860), Hospitalet de Llobregat, Barcelona
H. Marques de Valdecilla ( Site 0865), Santander, Cantabria
Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 0851), Badalona, Cataluna
Hospital Clinic de Barcelona ( Site 0852), Barcelona, Cataluna
Hospital de la Santa Creu i Sant Pau-Oncología Médica ( Site 0862), Barcelona, Cataluna
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0876), Santiago de Compostela, La Coruna
Hospital Universitario Insular de Gran Canaria ( Site 0867), Las Palmas de Gran Canaria, Las Palmas
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 0877), Madrid, Madrid, Comunidad De
Hospital Universitario Puerta de Hierro-Majadahonda ( Site 0861), Majadahonda, Madrid
Hospital Universitario Quiron Madrid ( Site 0868), Pozuelo de Alarcon, Madrid
H.R.U Malaga - Hospital General ( Site 0884), Málaga, Malaga
Hospital Universitari Sant Joan de Reus-Oncology ( Site 0874), Reus, Tarragona
Instituto Valenciano de Oncologia - IVO ( Site 0863), Valencia, Valenciana, Comunitat
Hospital Clinico de Valencia ( Site 0858), Valencia, Valenciana, Comunitat
Hospital General Universitario de Valencia ( Site 0854), Valencia, Valenciana, Comunitat
Hospital Arnau de Vilanova ( Site 0866), Valencia, Valenciana, Comunitat
Hospital Universitari i Politecnic La Fe ( Site 0875), València, Valencia
Hospital General Universitario de Alicante-Oncologia ( Site 0881), Alicante, Not set
Parc de Salut Mar - Hospital del Mar-Oncologia ( Site 0873), Barcelona, Not set
H.U. Vall de Hebron ( Site 0850), Barcelona, Not set
Hospital Universitario Reina Sofia ( Site 0885), Cordoba, Not set
Complejo Hospitalario de Jaén-Servicio de Oncología Médica ( Site 0879), Jaen, Not set
Hospital Universitario Gregorio Maranon ( Site 0864), Madrid, Not set
Clinica Universitaria de Navarra ( Site 0855), Madrid, Not set
Hospital Clinico San Carlos ( Site 0857), Madrid, Not set
Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 0871), Madrid, Not set
Hospital General Universitario 12 de Octubre ( Site 0856), Madrid, Not set
Hospital Universitario La Paz ( Site 0853), Madrid, Not set
Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid, ( Site 0869), Madrid, Not set
Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 0880), Sevilla, Not set
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 0872), Sevilla, Not set
Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 0882), Sevilla, Not set
Hospital Clinico Universitario Lozano Blesa ( Site 0859), Zaragoza, Not set
Karolinska Universitetssjukhuset Solna ( Site 0802), Stockholm, Stockholms Lan
Blod och Tumorssjukdomar. Akademiska sjukhuset ( Site 0801), Uppsala, Uppsala Lan
Norrlands Universitetssjukhus ( Site 0800), Umea, Vasterbottens Lan
Sahlgrenska Universitetssjukhuset-Department of Oncology CTU Clinical Trial Unit ( Site 0803), Gothenburg, Vastra Gotalands Lan
University Hospital Basel ( Site 0752), Basel, Basel-Stadt
Hôpitaux Universitaires de Genève (HUG) ( Site 0753), Genève, Geneve
Universitaetsspital Zuerich ( Site 0750), Zürich-Flughafen, Zurich
Kaohsiung Chang Gung Memorial Hospital ( Site 3203), Kaohsiung, Not set
China Medical University Hospital ( Site 3204), Taichung, Not set
National Cheng Kung University Hospital ( Site 3201), Tainan, Not set
National Taiwan University Hospital ( Site 3200), Taipei, Not set
Mackay Memorial Hospital ( Site 3205), Taipei, Not set
Taipei Veterans General Hospital ( Site 3202), Taipei, Not set
Koo Foundation Sun Yat-Sen Cancer Center-Gynecology, Obstetrics, and women's health ( Site 3207), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch ( Site 3206), Taoyuan, Not set
Faculty of Medicine - Khon Kaen University ( Site 2366), Muang, Khon Kaen
Chulalongkorn University ( Site 2363), Bangkok, Krung Thep Maha Nakhon
Ramathibodi Hospital ( Site 2364), Bangkok, Krung Thep Maha Nakhon
Faculty of Medicine Siriraj Hospital ( Site 2365), Bangkok, Krung Thep Maha Nakhon
Acibadem Altunizade Hospital-Oncology ( Site 1317), Üsküdar /Istanbul, Istanbul
Acibadem Adana Hospital-Pediatric Hematology-Oncology ( Site 1312), Adana, Not set
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1307), Adana, Not set
Adana Sehir Egitim ve Arastirma Hastanesi ( Site 1324), Adana, Not set
Ankara University Hospital Cebeci ( Site 1306), Ankara, Not set
Hacettepe Universitesi-oncology hospital ( Site 1304), Ankara, Not set
Gazi University Health Research and Application Center Gazi Hospital ( Site 1325), Ankara, Not set
Ankara City Hospital-Medical Oncology ( Site 1311), Ankara, Not set
Baskent Universitesi Ankara Hastanesi ( Site 1303), Ankara, Not set
Akdeniz Universitesi Hastanesi-Medical Onkology ( Site 1318), Antalya, Not set
Memorial Antalya Hospital-Oncology ( Site 1315), Antalya, Not set
Trakya Universitesi Tip Fakultesi ( Site 1301), Edirne, Not set
Bezmialem Vakf Üniversitesi-Oncology ( Site 1308), Istanbul, Not set
Istanbul University Capa Campus ( Site 1314), Istanbul, Not set
Acibadem Universitesi Atakent Hastanesi ( Site 1319), Istanbul, Not set
Acıbadem Maslak Hastanesi-Medical Oncology ( Site 1321), İstanbul, Not set
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1302), Istanbul, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1316), Istanbul, Not set
Marmara Universitesi Pendik Egitim Arastirma Hastanesi-Medical Oncology ( Site 1305), Istanbul, Not set
Ege Universitesi Tip Fakultesi Hastanesi ( Site 1300), Izmir, Not set
Dokuz Eylul Universitesi Hastanesi ( Site 1323), İzmir, Not set
I.E.U. Medical Point Hastanesi-Oncology ( Site 1310), Izmir, Not set
Kocaeli Üniversitesi ( Site 1313), Kocaeli, Not set
Inonu Universitesi ( Site 1309), Malatya, Not set
Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council ( Site 3650), Dnipro, Dnipropetrovska Oblast
MI Kryvyi Rih Oncology Dispensary of Dnipropetrovsk Regional-Chemotherapy department ( Site 3657), Kryvyi Rih, Dnipropetrovska Oblast
Communal Non-Commercial Enterprise "Prykarpatski Clinical Oncological Center" of Ivano-Frankivsk Reg ( Site 3663), Ivano-Frankivsk, Ivano-Frankivska Oblast
MNPE Regional Center of Oncology ( Site 3665), Kharkiv, Kharkivska Oblast
SO"Grigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine" ( Site 3666), Kharlkiv, Kharkivska Oblast
Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 3656), Kropyvnytskyi, Kirovohradska Oblast
Asklepion Medical Center ( Site 3667), Khodosivka, Kyivska Oblast
National Cancer Institute-Department of Minimally Invasive and Endoscopic Surgery, Interventional R ( Site 3658), Kyiv, Kyivska Oblast
Municipal non-profit enterprise "Kyiv City Clinical Oncology Center" of executive body of Kyiv City ( Site 3651), Kyiv, Kyivska Oblast
Municipal institution of Lviv regional council Lviv Oncology-Chemotherapy ( Site 3653), Lviv, Lvivska Oblast
Odessa Regional Oncology Center ( Site 3655), Odessa, Odeska Oblast
Sumy regional clinical oncological dispensary-Oncothoracic department ( Site 3661), Sumy, Sumska Oblast
Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council" ( Site 3662), Vinnytsia, Vinnytska Oblast
Transcarpathian Regional Clinical Oncology Center-Chemotherapy dept. ( Site 3652), Uzhhorod, Zakarpatska Oblast
Municipal non-profit enterprise "Zaporizhzhia regional clinical hospital" of Zaporizhzhia regional c ( Site 3664), Zaporizhzhia, Zaporizka Oblast
Aberdeen Royal Infirmary-Department of Oncology ( Site 0521), Aberdeen, Aberdeen City
Addenbrookes Hospital ( Site 0522), Cambridge, Cambridgeshire
Western General Hospital ( Site 0502), Edinburgh, Edinburgh, City Of
The Christie ( Site 0516), Manchester, England
Weston Park Hospital ( Site 0519), Sheffield, England
Mid Essex Hospitals Service Trust. Broomfield Hospital ( Site 0503), Broomfield, Essex
The Beatson West of Scotland Cancer Centre ( Site 0506), Glasgow, Glasgow City
Royal Preston Hospital ( Site 0518), Preston, Lancashire
Barts Health NHS Trust ( Site 0512), London, London, City Of
University College London Hospital-Cancer Clinical Trials Unit ( Site 0520), London, London, City Of
Royal Free Hospital ( Site 0507), London, London, City Of
Royal Marsden Hospital ( Site 0505), London, London, City Of
Sarah Cannon Research UK ( Site 0504), London, London, City Of
Belfast City Hospital ( Site 0508), Belfast, Northern Ireland
Nottingham University Hospitals NHS Trust ( Site 0510), Nottingham, Nottinghamshire
St James University Hospital ( Site 0509), Leeds, Not set
The Royal Marsden NHS Foundation Trust. ( Site 0513), Sutton, Not set
New Cross Hospital-Department of Oncology ( Site 0517), Wolverhampton, Not set
Conditions: Solid Tumors, Hematologic Malignancies
A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
Recruiting
This study will test the safety of a drug called PF-08046031 in participants with melanoma and other solid tumors that have no current approved treatment or have spread through the body. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. The study will have 3 parts. Part A and B of the study will find out how much PF-08046031 should be given to participants. Part C will use the information from Parts A and B to see if... Read More
This study will test the safety of a drug called PF-08046031 in participants with melanoma and other solid tumors that have no current approved treatment or have spread through the body. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. The study will have 3 parts. Part A and B of the study will find out how much PF-08046031 should be given to participants. Part C will use the information from Parts A and B to see if PF-08046031 is safe and if it works to treat solid tumor cancers. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/14/2025
Locations: The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate, Los Angeles, California +12 locations
The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate, Los Angeles, California
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
UCSF Medical Center, Investigational Pharmacy, San Francisco, California
The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate (Emergency Back-up only), Santa Monica, California
Sarah Cannon Research Institute at HealthONE - SCRI - PPDS, Denver, Colorado
Florida Cancer Specialists, Orlando, Florida
Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
UPMC Shadyside Hospital, Pittsburgh, Pennsylvania
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona]
Karolinska Universitetssjukhuset Solna, Solna, Stockholms LÄN [se-01]
Sarah Cannon Research Institute UK, London, London, CITY OF
The Royal Marsden NHS Foundation Trust, Sutton, Not set
Conditions: Malignant Melanoma, Melanoma, Metastatic Melanoma, Solid Tumors
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
Recruiting
The purpose of this clinical trial (called the FLOTILLA study) is to give continued access to the study medicines, as well as safety follow-up, for participants in prior clinical trials of encorafenib and/or binimetinib.
All participants who took part in earlier encorafenib and/or binimetinib studies may participate the FLOTILLA study if they are still benefiting from the use of the study medicines. This will be determined by the study doctor. People may not participate in the FLOTILLA study if... Read More
The purpose of this clinical trial (called the FLOTILLA study) is to give continued access to the study medicines, as well as safety follow-up, for participants in prior clinical trials of encorafenib and/or binimetinib.
All participants who took part in earlier encorafenib and/or binimetinib studies may participate the FLOTILLA study if they are still benefiting from the use of the study medicines. This will be determined by the study doctor. People may not participate in the FLOTILLA study if they have not enrolled in a prior study of encorafenib or binimetinib.
Participants that had enrolled but had stopped receiving the study treatment in a prior study cannot enrolled in this study. Participants in the FLOTILLA study will receive encorafenib and/or binimetinib at the same dose and frequency as in their prior study, for up to about 5 years. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/12/2025
Locations: St. Joseph's Hospital and Medical Center, Phoenix, Arizona +62 locations
St. Joseph's Hospital and Medical Center, Phoenix, Arizona
St. Joseph's Hospital and Medical Center, Phoenix, Arizona
Emory University Hospital Midtown, Atlanta, Georgia
Emory University Hospital, Atlanta, Georgia
Investigational Drug Service Emory University Clinic, Atlanta, Georgia
Winship Cancer Institute of Emory University, Atlanta, Georgia
Massachusetts General Hospital, Boston, Massachusetts
HealthPartners Cancer Research Center, Saint Paul, Minnesota
Regions Hospital Pharmacy, Saint Paul, Minnesota
HealthPartners Specialty Center, Saint Paul, Minnesota
Siteman Cancer Center, Saint Louis, Missouri
Barnes-Jewish Hospital, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
MSK Basking Ridge, Basking Ridge, New Jersey
Rockefeller Outpatient Pavilion (53rd Street), New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Peter MacCallum Cancer Centre, Melbourne, Victoria
Liga Norte Riograndense Contra o Câncer, Natal, RIO Grande DO Norte
ONCOSITE - Centro de Pesquisa Clinica em Oncologia, Ijui, RIO Grande DO SUL
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, SÃO Paulo
BP - A Beneficencia Portuguesa de São Paulo, Sao Paulo, SÃO Paulo
Real e Benemerita Associacao Portuguesa de Beneficencia, Sao Paulo, SÃO Paulo
Princess Margaret Cancer Centre, Toronto, Ontario
Jewish General Hospital, Montreal, Quebec
Vseobecna fakultni nemocnice v Praze, Prague 2, Praha 2
Hopital Claude Huriez - CHU de Lille, Lille, Nord
Gustave Roussy, Villejuif, Val-de-marne
Universitaetsklinikum Tuebingen, Tübingen, Baden-württemberg
Otto-von-Guericke-Universitat Magdeburg, Magdeburg, Sachsen-anhalt
Charité Universitaetsmedizin Berlin - Campus Mitte, Berlin, Not set
Debreceni Egyetem Klinikai Kozpont, Debrecen, Not set
Debreceni Egyetem Klinikai Kozpont, Debrecen, Not set
Rambam Health Care Campus, Haifa, Hatsafon
Instituto Tumori Giovanni Paolo II, Bari, Puglia
Istituto Nazionale Tumori Regina Elena, Rome, Roma
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set
Istituto Europeo di Oncologia IRCCS, Milano, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Not set
Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [seoul]
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [seoul]
Radboudumc, Nijmegen, Gelderland
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Noord-holland
Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL), Amsterdam, Noord-holland
Isala, locatie Zwolle, Zwolle, Not set
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Lisboa
Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set
N.N.Petrov Research Institute of Oncology, Saint Petersburg, Sankt-peterburg
Fed State Budgetary Inst "N.N. Blokhin Med Center of Oncology" MHRF, Moscow, Not set
N.N.Petrov Research Institute of Oncology, Saint Petersburg, Not set
Narodny onkologicky ustav, Bratislava, Bratislavský KRAJ
CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [LA Coruña]
Institut Català d'Oncologia (ICO) - Badalona, Badalona, Barcelona [barcelona]
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona]
Hospital Clinic de Barcelona, Barcelona, Catalunya [cataluña]
Hospital Clínic de Barcelona, Barcelona, Catalunya [cataluña]
Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Lleida [lérida]
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad DE
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Universitario HM Sanchinarro, Madrid, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Central de Asturias, Oviedo, Not set
Lancashire Teaching Hospitals NHS Foundation Trust - Royal Preston Hospital, Preston, Lancashire
Conditions: Solid Tumors
Screening Study for Participants With Malignant Tumors
Recruiting
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: Arizona Oncology Associates, PC - HOPE, Tucson, Arizona +161 locations
Arizona Oncology Associates, PC - HOPE, Tucson, Arizona
Southern California Kaiser Permanente, San Diego, California
Rocky Mountain Cancer Centers-Penrose Pavillion, Longmont, Colorado
Oregon Health Sciences Uni, Portland, Oregon
Hillman Cancer Center, Pittsburgh, Pennsylvania
Thompson Cancer Survival Center, Knoxville, Tennessee
Baptist Cancer Center, Memphis, Tennessee
Texas Oncology, P.A., Austin, Texas
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas
Texas Oncology, P.A., San Antonio, Texas
Texas Oncology- Northeast Texas, Tyler, Texas
Oncology & Hematology Associates of Southwest Virginia, Inc, Blacksburg, Virginia
Northwest Cancer Specialists, Vancouver, Washington
Lifehouse, Camperdown, New South Wales
GenesisCare North Shore, St Leonards, New South Wales
Westmead Hospital, Westmead, New South Wales
Peter MacCallum Cancer Centre, Melbourne, Victoria
One Clinical Research, Nedlands, Western Australia
GHdC Site Les Viviers, Charleroi, Not set
UZ Gent, Gent, Not set
Hospital Sao Rafael - HSR, Salvador, Bahia
Crio - Centro Regional Integrado de Oncologia, Fortaleza, Ceará
Oncocentro Belo Horizonte, Belo Horizonte, Minas Gerais
COT - Centro Oncologico do Triangulo, Uberlandia, Minas Gerais
Universidade de Caxias do Sul - Rio Grande do Sul, Caxias do Sul, Rio Grande Do Sul
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul
Hospital Sao Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceicao, Porto Alegre, Rio Grande Do Sul
Hospital de Clínicas de Porto Alegre X, Porto Alegre, Rio Grande Do Sul
Clínica de Oncologia Reichow, Blumenau, Santa Catarina
Hospital de Cancer de Barretos, Barretos, São Paulo
Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, São Paulo
Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo
Oncoclinicas Rio de Janeiro S.A., Rio de Janeiro, Not set
Sunnybrook Health Sciences Centre, Toronto, Ontario
K2 Oncology, Providencia, Not set
OrlandiOncología, Santiago, Not set
Centro de Estudios Clínicos SAGA, Santiago, Not set
RedSalud Vitacura, Santiago, Not set
James Lind Centro de Investigación Del Cáncer, Temuco, Not set
Clinica De La Costa, Barranquilla, Not set
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C., Not set
Hospital Universitario San Ignacio, Bogota, Not set
Instituto Cancerología Medellin, Medellin, Not set
Clinica CIMCA, San José, Not set
ICIMED Instituto de Investigación en Ciencias Médicas, San José, Not set
CHU Angers,Service de Pneumologie, Angers, Not set
Polyclinique Bordeaux Nord Aquitaine, Bordeaux, Not set
Centre Francois Baclesse, Caen, Not set
Centre Leon Berard, Lyon, Not set
Hopital Haut Leveque Chu de Bordeaux, Pessac, Not set
CHU Strasbourg - Nouvel Hopital Civil, Strasbourg, Not set
Hia Sainte Anne, Toulon, Not set
Zentralklinikum Augsburg, Augsburg, Not set
Klinikum Esslingen, Esslingen, Not set
Asklepios Klinik Gauting, München-Gauting, Not set
LMU Klinikum der Universität München, Medizinische Klinik und Poliklinik V, Campus Innenstadt, München, Not set
Klinikum rechts der Isar der TU Muenchen, München, Not set
Universitätsklinikum Regensburg, Regensburg, Not set
Universitätsklinikum Würzburg, Würzburg, Not set
Queen Mary Hospital, Hong Kong, Not set
Rajiv Gandhi Cancer Inst.&Research Center, New Delhi, Delhi
Medanta -The Medicity, Gurgaon, Haryana
Tata Memorial Hospital, Mumbai, Maharashtra
Apollo Gleneagles Hospital, Kolkata, WEST Bengal
Rambam Medical Center, Haifa, Not set
Rabin Medical Center-Beilinson Campus, Petach Tikva, Not set
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola, Emilia-Romagna
IRCCS Istituto Regina Elena (IFO), Roma, Lazio
Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio
IRCCS A.O.U San MArtino - IST, Genova, Liguria
Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia
Irccs Istituto Europeo di Oncologia (IEO), Milano, Lombardia
Asst Grande Ospedale Metropolitano Niguarda, Milano, Lombardia
A.O. Universitaria S. Luigi Gonzaga, Orbassano, Piemonte
IRCCS Giovanni Paolo II Istituto Oncologico, Bari, Puglia
Azienda Ospedaliero-Universitaria Careggi, Firenze, Toscana
IRCCS Istituto Oncologico Veneto (IOV), Padova, Veneto
Aichi Cancer Center Hospital, Aichi, Not set
Hirosaki University Hospital, Aomori, Not set
Shikoku Cancer Center, Ehime, Not set
NHO Kyushu Cancer Center, Fukuoka, Not set
Kurume University Hospital, Fukuoka, Not set
Kobe City Medical Center General Hospital, Hyogo, Not set
National Hospital Organization Himeji Medical Center, Hyogo, Not set
Kagoshima University Hospital, Kagoshima, Not set
Kanagawa Cancer Center, Kanagawa, Not set
Kumamoto University Hospital, Kumamoto, Not set
Sendai Kousei Hospital, Miyagi, Not set
Nara Medical University Hospital, Nara, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Okayama University Hospital, Okayama, Not set
Kurashiki Central Hospital, Okayama, Not set
Kindai University Hospital, Osaka-sayama, Not set
Osaka City General Hospital, Osaka, Not set
Osaka International Cancer Institute, Osaka, Not set
NHO Kinki Chuo Chest Medical Center, Osaka, Not set
Shizuoka Cancer Center, Shizuoka, Not set
Juntendo University Hospital, Tokyo, Not set
Komagome Hospital, Tokyo, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Tottori University Hospital, Tottori, Not set
National Hospital Organization Yamaguchi - Ube Medical Center, Yamaguchi, Not set
Chungbuk National University Hospital, Cheongju-si, Not set
Kyungpook National University Chilgok Hospital, Daegu, Not set
Pusan National University Yangsan Hospital, Gyeongsangnam-do, Not set
Chonnam National University Hwasun Hospital, Jeollanam-do, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Kangbuk Samsung Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco
Clinstile S.A de C.V., Mexico City, Mexico CITY (federal District)
Centro Oncologico Internacional, Mexico D.F., Mexico CITY (federal District)
Centro de Investigación Oncologica Galerias, Aguascalientes, Not set
ARKE Estudios Clínicos S.A. de C.V., Ciudad de México, Not set
Instituto Nacional de Cancerologia, Mexico City, Not set
Maastricht University Medical Center, Maastricht, Not set
Auckland City Hospital, Cancer and Blood Research, Auckland, Not set
Oslo university hospital Radiumhospitalet, Oslo, Not set
Instytut Genetyki i Immunologii GENIM, Lublin, Not set
Dolno?l?skie Centrum Chorób P?uc we Wroc?awiu, Wroc?aw, Not set
University Clinical Centre of Serbia, Belgrade, Not set
Hospital Medical Center Bezanijska kosa, Belgrade, Not set
Univ Clinical Center Kragujevac, Kragujevac, Not set
Institute for pulmonary diseases of Vojvodina, Sremska Kamenica, Not set
National Cancer Centre, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Complejo Hospitalario Universitario Insular?Materno Infantil, Las Palmas de Gran Canaria, LAS Palmas
Hospital General Univ. de Alicante, Alicante, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Regional Universitario Carlos Haya, Malaga, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Taipei Medical University Shuang Ho Hospital, New Taipei City, Not set
National Cheng Kung Univ Hosp, Tainan, Not set
National Taiwan Uni Hospital, Taipei City, Not set
Taipei Veterans General Hospital, Taipei City, Not set
Taipei Medical University Hospital, Taipei, Not set
Taipei Municipal Wan Fang Hospital, Taipei, Not set
Chang Gung Memorial Hospital - Linkou, Taoyuan, Not set
Taichung Veterans General Hospital, Xitun Dist., Not set
National Cancer Institute, Bangkok, Not set
Rajavithi Hospital, Bangkok, Not set
Siriraj Hospital, Bangkok, Not set
Maharaj Nakorn Chiang Mai Hosp, Chang Mai, Not set
Oncology Unit, Faculty of Medicine, Vajira Hospital, Dusit, Not set
Srinagarind Hospital, Khon Kaen, Not set
Central Chest Institute of Thailand, Nonthaburi, Not set
Songklanagarind Hospital, Songkhla, Not set
Ataturk Sanatoryum Egitim Ve Arastirma Hastanesi, Ankara, Not set
Gazi Uni Medical Faculty Hospital, Ankara, Not set
Liv Hospital Ankara, Ankara, Not set
Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Tibbi Onkoloji, Bakirkoy / Istanbul, Not set
Dicle University Faculty of Medicine, Diyarbakir, Not set
Ataturk University Medical Faculty Yakutiye Research Hospital Medical Oncology Department, Erzurum, Not set
Medipol University Medical Faculty, Istanbul, Not set
Marmara Uni Faculty of Medicine, Istanbul, Not set
Medikal Park Samsun, Samsun, Not set
Medical Park Seyhan Hospital, Seyhan, Not set
Barts & London School of Med, London, Not set
Royal Marsden Hospital, London, Not set
Christie Hospital Nhs Trust, Manchester, Not set
Conditions: Solid Tumors
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Recruiting
The purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of ORIC-114 as a Single Agent or in Combination with Chemotherapy when administered to patients with advanced solid tumors harboring an EGFR or HER2 alteration.
The purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of ORIC-114 as a Single Agent or in Combination with Chemotherapy when administered to patients with advanced solid tumors harboring an EGFR or HER2 alteration. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/31/2025
Locations: City of Hope, Duarte, California +41 locations
City of Hope, Duarte, California
City of Hope, Huntington Beach, California
City of Hope, Irvine, California
City of Hope, Long Beach, California
University of California, San Francisco, San Francisco, California
Yale Cancer Center, New Haven, Connecticut
Georgetown University, Washington, District of Columbia
Mayo Clinic, Jacksonville, Florida
Moffitt Cancer Center, Tampa, Florida
Northwestern University, Chicago, Illinois
Dana Farber Cancer Institute, Boston, Massachusetts
Mayo Clinic, Rochester, Minnesota
NYU Langone Health Perlmutter Cancer Center, New York, New York
Duke Cancer Institute, Durham, North Carolina
University of Pennsylvania, Philadelphia, Pennsylvania
Spartanburg Regional Healthcare System, Spartanburg, South Carolina
Next Oncology, Fairfax, Virginia
Chris O'Brien Lifehouse, Camperdown, Not set
Peter MacCallum Cancer Centre, Melbourne, Not set
One Clinical Research, Hollywood Medical Centre, Nedlands, Not set
Sydney Adventist Health, Sydney, Not set
Princess Margaret Cancer Centre, Toronto, Ontario
The Chinese University of Hong Kong, Shatin, Not set
Chungbuk University Hospital, Cheongju-si, Not set
National Cancer Center, Goyang-si, Not set
Catholic University of Korea, St, Vincent Hospital, Gyeonggi-do, Not set
Gachon University Hospital, Incheon, Not set
Seoul National Bundang Hospital, Seongnam-si, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Sultan Ahmad Shah Medical Centre at International Islamic University Malaysia (IIUM), Kuantan, Pahang
Pulau Pinang Hospital, George Town, Penang
Sarawak General Hospital (SGH), Kuching, Sarawak
Hospital Kuala Lumpur, Kuala Lumpur, Not set
University of Malaya Medical Center (UMMC), Kuala Lumpur, Not set
Medical University of Gdańsk, Gdańsk, Not set
NEXT Oncology - Barcelona, Barcelona, Not set
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Not set
NEXT Oncology - Madrid, Madrid, Not set
National Taiwan University Hospital, Taipei, Not set
The Christie NHS Foundation Trust, Manchester, England
Conditions: Solid Tumors
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
Recruiting
This study is open to adults with different types of advanced cancer. People can take part if previous treatment was not successful, or no treatment exists.
The purpose of this study is to find the highest dose of a medicine called BI 1703880 that people with advanced cancer can tolerate when taken together with ezabenlimab.
BI 1703880 and ezabenlimab are medicines that may help the immune system fight cancer. In this study, BI 1703880 is given to people for the first time.
Participants get B... Read More
This study is open to adults with different types of advanced cancer. People can take part if previous treatment was not successful, or no treatment exists.
The purpose of this study is to find the highest dose of a medicine called BI 1703880 that people with advanced cancer can tolerate when taken together with ezabenlimab.
BI 1703880 and ezabenlimab are medicines that may help the immune system fight cancer. In this study, BI 1703880 is given to people for the first time.
Participants get BI 1703880 and ezabenlimab as infusions into a vein. During the first 6 weeks, they get BI 1703880 once a week. Later, they get BI 1703880 every 3 weeks. After the first 3 weeks, they get ezabenlimab in addition every 3 weeks.
Participants can get BI 1703880 for up to 1 year and ezabenlimab for up to 2 years as long as they benefit from treatment and can tolerate it. During this time, they visit the study site regularly. At these visits, the doctors check participants' health and take note of any unwanted effects. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: Valkyrie Clinical Trials, Los Angeles, California +12 locations
Valkyrie Clinical Trials, Los Angeles, California
Yale University School of Medicine, New Haven, Connecticut
John Theurer Cancer Center, Hackensack, New Jersey
National Cancer Center Hospital East, Chiba, Kashiwa, Not set
Saitama Medical University International Medical Center, Saitama, Hidaka, Not set
Japanese Foundation for Cancer Research, Tokyo, Koto-ku, Not set
Hospital Vall d'Hebron, Barcelona, Not set
CIO Clara Campal, Madrid, Not set
Instituto Valenciano de Oncología, Valencia, Not set
Hospital Clínico de Valencia, Valencia, Not set
The Royal Marsden Hospital, Chelsea, London, Not set
Churchill Hospital, Oxford, Not set
The Royal Marsden Hospital, Sutton, Sutton, Not set
Conditions: Solid Tumors
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Recruiting
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors harboring BRAF fusions, or in participants with rare BRAF V600-mutated solid tumors, melanoma, thyroid, or recurrent primary CNS tumors.
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors harboring BRAF fusions, or in participants with rare BRAF V600-mutated solid tumors, melanoma, thyroid, or recurrent primary CNS tumors. Read Less
Gender:
ALL
Ages:
10 years and above
Trial Updated:
07/23/2025
Locations: UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California +59 locations
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
University of California Los Angeles Rheumatology, Westwood, California
University of Miami Hospital and Clinics, Miami, Florida
The John Hopkins Hospital, Baltimore, Maryland
Maryland Oncology Hematology- Columbia, Rockville, Maryland
Tufts Medical Center, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
St. Luke's Hospital, Duluth, Minnesota
Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph, Missouri
Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha, Nebraska
Overlook Medical Center, Summit, New Jersey
Columbia University Irving Medical Center, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Nationwide Children's Hospital, Columbus, Ohio
Taylor Cancer Research Center, Maumee, Ohio
Toledo Clinic Cancer Center, Toledo, Ohio
Thomas Jefferson University, Philadelphia, Pennsylvania
Lifespan Cancer Institute - Rhode Island Hospital, Providence, Rhode Island
Baylor Scott & White Research Institute, Dallas, Texas
Baylor Scott & White Medical Center, Temple, Texas
University of Washington School of Medicine, Seattle, Washington
West Virginia University Health Sciences Campus, Morgantown, West Virginia
Newcastle Private Hospital, New Lambton Heights, New South Wales
Orange Health Service, Orange, New South Wales
Sydney Children's Hospital Network - Randwick, Randwick, New South Wales
The Alfred, Melbourne, Victoria
Sunny brook Health Sciences Centre- Bayview Campus, Toronto, Ontario
Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec
Institut Bergonie, Bordeaux Cedex, Aquitaine
Hôpital Nord de Marseille, Marseille, Bouches-du-Rhône
Hôpital Morvan, Brest, Finistère
Hôpital Universitaire Pitié Salpêtrière, Paris, Ile-de-France
Institut de Cancerologie de l'Ouest- Angers, Angers, Pays De La Loire
Gustave Roussy, Villejuif, Val-de-Marne
Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, Not set
Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg
Krankenhaus Nordwest, Frankfurt, Hessen
Charité - Universitätsmedizin Berlin, Berlin, Not set
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST, Meldola, Forli-Cesena
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Naples
Istituto Europeo di Oncologia, Milano, Not set
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele, Milan, Not set
Catholic University of Korea Saint Vincent's Hospital, Suwon-si, Gyeonggi-do
Seoul National University Hospital, Suwon, Gyeonggido
Dong-A University Hospital, Busan, Gyeongsangnam-do
Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do
Seoul National University Hospital, Seoul, Seoul Teugbyeoisi
Severance Hospital, Seoul, Seoul Teugbyeolsi
Haukeland Univeritetssjukehus, Bergen, Hordaland
Oslo Universitetssykehus-Radiumhospitalet, Oslo, Not set
Hospital Clinico Universitarlo de Santiago, Santiago De Compostela, A Coruña
Hospital Clinico Universitarlo de Valencia, València, Valencia
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Infantil Universitario Niño Jesús, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario Virgen del Rocío, Sevilla, Not set
Skånes Universitetssjukhus, Lund, Skåne Län
Karolinska Universitetssjukhuset, Solna, Stockholms Län
The Christie NHS Foundation Trust, Manchester, England
Sarah Cannon Research Institute, London, Not set
Conditions: Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors, Melanoma BRAF V600E/K Mutated, Thyroid Cancer
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
Recruiting
The purpose of this study is to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone and in combination in participants with solid tumors.
The purpose of this study is to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone and in combination in participants with solid tumors. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: University of Arizona, Tucson, Arizona +33 locations
University of Arizona, Tucson, Arizona
Angeles Clinic and Research Institute, Los Angeles, California
The George Washington Cancer Center, Washington, District of Columbia
Orlando Health Cancer Institute, Orlando, Florida
Florida Cancer Specialists, Sarasota, Florida
H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Massachusetts General Hospital, Boston, Massachusetts
Henry Ford Cancer, Detroit, Michigan
Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, New Jersey
NYU Langone Medical Center, New York, New York
Duke Cancer Institute, Durham, North Carolina
The Cleveland Clinic Foundation, Cleveland, Ohio
Providence Portland Medical Center, Portland, Oregon
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
SCRI, Oncology Partners, Nashville, Tennessee
UT Southwest Medical Center, Dallas, Texas
Chris O'Brien Lifehouse, Camperdown, New South Wales
St Vincents Hospital Sydney, Darlinghurst, New South Wales
Scientia Clinical Research Ltd, Randwick, New South Wales
Westmead Hospital-Cnr Hawkesbury and Darcy Road, Westmead, New South Wales
The Queen Elizabeth Hospital, Woodville South, South Australia
PASO Medical, Frankston, Victoria
One Clinical Research Perth, Perth, Western Australia
National Cancer Center East, Chiba, Not set
Kindai University Hospital, Osaka, Not set
National Cancer Center Hospital, Tokyo, Not set
The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Tokyo, Not set
NHS Tayside, Dundee, Scotland
Imperial College Healthcare NHS Trust, London, Not set
Royal Mardsen London, London, Not set
University College of London, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Oxford University Hospitals NHS Foundation Trust, Oxford, Not set
Royal Mardsen Sutton, Sutton, Not set
Conditions: Solid Tumors
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Recruiting
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias, lymphomas, and solid tumors.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias, lymphomas, and solid tumors. Read Less
Gender:
ALL
Ages:
Between 1 year and 17 years
Trial Updated:
06/30/2025
Locations: Ghent University Hospital, Ghent, Not set +31 locations
Ghent University Hospital, Ghent, Not set
Universitair Ziekenhuis (Uz) Leuven, Leuven, Not set
The Finsen Centre National Hospital, Copenhagen, Not set
Hopital Robert Debre, Paris, Not set
Armand Trousseau Hospital, Paris, Not set
Centre Hospitalier Universitaire de Poitiers, Poitiers, Not set
Chu de Rennes - Hospital Sud, Rennes, Not set
Universitaetsklinikum Erlangen - Medizinische Klinik 5, Erlangen, Not set
Universitatsklinikum Essen, Essen, Not set
Aou Policlinico S. Orsola-Malpighi, Bologna, Not set
Asst Degli Spedali Civili Di Brescia, Brescia, Not set
Ospedale Pediatrico G. Gaslini, Genova, Not set
Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano, Milan, Not set
Ospedale San Gerardo - Asst Monza, Monza, Not set
University of Milano Bicocca, Monza, Not set
Aorn Santobono Pausilipon, Naples, Not set
Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo, Pavia, Not set
Ospedale Pediatrico Bambino Gesu Irccs, Rome, Not set
A.O.U Citta Della Salute E Della Scienza Di Torino Presidio Ospedaliero Infantile Regina Margherita, Torino, Not set
Princess Maxima Center For Pediatric Oncology, Utrecht, Not set
Hospital General Universitario Vall D Hebron, Barcelona, Not set
Hospital Sant Joan de Deu de Manresa, Barcelona, Not set
Hospital Infantil Unversitario Nino Jesus, Madrid, Not set
Hospital Universitario de La Paz, Madrid, Not set
Hospital Universitari I Politecnic La Fe, Valencia, Not set
Karolinska Universitetssjukhuset Solna, Solna, Not set
Karolinska University Hospital Solna, Stockholm, Not set
University Hospital Birmingham, Birmingham, Not set
Royal Hospital For Sick Children Yorkhill Glasgow, Glasgow, Not set
Alder Hey Childrens Nhs Foundation Trust, Liverpool, Not set
The Royal Marsden Nhs Foundation Trust - Sutton, Sutton, Not set
The Royal Marsden NHS Foundation Trust, Sutton, Not set
Conditions: Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Leukemia, Lymphoma, Solid Tumors
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Recruiting
To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.
To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/27/2025
Locations: The Angeles Clinic and Research Institute, Los Angeles, California +35 locations
The Angeles Clinic and Research Institute, Los Angeles, California
Valkyrie Clinical Trials, Los Angeles, California
Dana Farber Cancer Institute, Boston, Massachusetts
Cancer and Hematology Centers of Western Michigan-Start Midwest, Grand Rapids, Michigan
Hackensack University Medical Center, Hackensack, New Jersey
Nyu Langone Health - Long Island Hospital, Mineola, New York
Laura and Isaac Perlmutter Cancer Center, New York, New York
University of Pennsylvania, Philadelphia, Pennsylvania
Lifespan Cancer Research Institute, Providence, Rhode Island
University of Texas Md Anderson Cancer Center, Houston, Texas
South Texas Accelerated Research Therapeutics, San Antonio, Texas
Rigshospitalet Uni of Hospital of Copenhagen, Copenhagen, Not set
Herlev Og Gentofte Hospital, Herlev, Not set
Odense University Hospital, Odense C, Not set
Vejle Hospital, Vejle, Not set
Centre Leon Berard, Lyon, Not set
Institut Gustave Roussy, Villejuif Cedex, Not set
Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, Not set
Irccs Istituto Clinico Humanitas, Rozzano, Not set
Centro Ricerche Cliniche Di Verona, Verona, Not set
Kansai Medical University Hospital, Hirakata, Not set
The Cancer Institute Hospital of Jfcr, Koto-ku, Not set
National Cancer Center Hospital, Tokyo, Not set
Start Barcelona, Barcelona, Not set
Hospital General Universitario Vall D Hebron, Barcelona, Not set
Fundacion Jimenez Diaz University Hospital, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Centro Integral Oncologico Clara Campal, Madrid, Not set
Istituto Oncologico Della Svizzera Italiana, Bellinzona, Not set
Centre Hospitalier Universitaire Vaudois (Chuv), Lausanne, Not set
Kantonsspital St. Gallen, St. Gallen, Not set
Cambridge University Hospitals Nhs Foundation Trust, Cambridge, Not set
Guys and St Thomas Nhs Foundation Trust, London, Not set
Imperial College Healthcare Nhs Trust - Hammersmith Hospital, London, Not set
The Christie Nhs Foundation Trust Uk, Manchester, Not set
Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust, Newcastle Upon Tyne, Not set
Conditions: Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Recruiting
To assess:
* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET fusion, primary CNS tumors harboring MET alterations, solid tumors harboring wild-type MET with overexpression of HGF and MET
* efficacy of APL-101 as an add-on therapy to EGFR inhibitor for the treatment of NSCLC harboring EGFR activating mutations and developed acquired resis... Read More
To assess:
* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET fusion, primary CNS tumors harboring MET alterations, solid tumors harboring wild-type MET with overexpression of HGF and MET
* efficacy of APL-101 as an add-on therapy to EGFR inhibitor for the treatment of NSCLC harboring EGFR activating mutations and developed acquired resistance with MET amplification and disease progression after documented CR or PR with 1st line EGFR inhibitors (EGFR-I) Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/24/2025
Locations: Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California +34 locations
Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California
Moffitt, Tampa, Florida
Dana Farber Cancer Institute, Boston, Massachusetts
University of North Carolina, Chapel Hill, North Carolina
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
University of Wisconsin, Madison, Wisconsin
St Vincents Hospital Melbourne, Melbourne, Not set
Cross Cancer Institute, Edmonton, Not set
McGill University Health Center - Research Institute, Montréal, Not set
Princess Margaret Hospital, Toronto, Not set
Cancer Care Manitoba, Winnipeg, Not set
CHRU de Brest - Hôpital Morvan, Brest, Not set
Centre Leon Berard, Lyon, Not set
Centre d'Essais Precoces en Cancerologie de Marseille, Marseille, Not set
Hopital Bichat - Claude Bernard - AP-HP, Paris, Not set
Gustave Roussy, Villejuif, Not set
Orszagos Koranyi Pulmonologiai Intezet, Budapest, Not set
Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabanya, Not set
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna, Not set
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Not set
Istituto Europeo di Oncologia, Milano, Not set
IRCCS Ospedale San Raffaele, Milan, Not set
Istituto Oncologico Veneto-I.R.C.C.S. - Ospedale Busonera, Padova, Not set
Private Medical Institution Euromedservice, Saint Petersburg, Not set
National Cancer Centre Singapore, Singapore, Not set
Hospital Germans Trias i Pujol, Badalona, Not set
Hospital Clinic Barcelona, Barcelona, Not set
Hospital del Mar, Barcelona, Not set
Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Instituto Valenciano de Oncologia, Valencia, Not set
National Taiwan University Hospital, Taipei City, Not set
University College London Hospital, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Royal Marsden Hospital - Surrey, Surrey Quays, Not set
Conditions: Advanced Cancer, Renal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC, Lung Cancer, Brain Tumor, Glioblastoma Multiforme, Solid Tumors, EGFR Gene Mutation, MET Amplification, HGF, Thyroid Cancer, Pancreatic Cancer, Colon Cancer, MET Alteration, MET Fusion, Exon 14 Skipping
1 - 12 of 14